Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors: A Systematic Review and Meta-analysis

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors: A Systematic Review and Meta-analysisrwcsadmin2020-02-15T18:52:32+00:00

Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors: A Systematic Review and Meta-analysis

Download

Back To All Presentations

Questions?
Click HERE for questions or to request additional information regarding the 2021 RWCS Symposia. Click HERE to register for the 2021 Symposia (coming soon).